Showing results (171-180 of 330) with videos related to
Sort By:
Pageof 33
Cancers|June 24, 2022
Real-World Data on Ramucirumab Therapy including Patients Who Experienced Two or More Systemic Treatments: A Multicenter StudyYutaka Yasui, Masayuki Kurosaki, Kaoru Tsuchiya, et al.Hepatology Research : the Official Journal of the Japan Society of Hepatology|February 9, 2026
Borderline Resectable Classification Identifies Candidates for Conversion Therapy in Unresectable Hepatocellular Carcinoma Treated With Atezolizumab and BevacizumabYasuto Takeuchi, Masahiko Sue, Nozomi Miyake, et al.Journal of Hepatology|September 22, 2018
Development of pre and post-operative models to predict early recurrence of hepatocellular carcinoma after surgical resectionAnthony W H Chan, Jianhong Zhong, Sarah Berhane, et al.Cancer Medicine|December 22, 2018
Clinical features of lenvatinib for unresectable hepatocellular carcinoma in real-world conditions: Multicenter analysisAtsushi Hiraoka, Takashi Kumada, Kazuya Kariyama, et al.Journal of Gastroenterology|June 28, 2022
Chronological change in serum albumin as a prognostic factor in patients with hepatocellular carcinoma treated with lenvatinib: proposal of albumin simplified grading based on the modified albumin-bilirubin score (ALBS grade)Kazuya Kariyama, Atsushi Hiraoka, Takashi Kumada, et al.Acta Medica Okayama|October 28, 2024
Prognostic Efficacy of the Albumin Grade in Patients with Hepatocellular CarcinomaYuichi Hirano, Kazuhiro Nouso, Kazuya Kariyama, et al.Alimentary Pharmacology & Therapeutics|May 4, 2026
Superior Efficacy of Tenofovir Alafenamide Compared With Entecavir in Reducing Hepatitis B Surface Antigen: A Multicentre Propensity Score-Matched Study Using Linear Mixed-Effects ModelsTakashi Kumada, Masanori Atsukawa, Norio Itokawa, et al.Hepatology Research : the Official Journal of the Japan Society of Hepatology|November 29, 2018
Efficacy and safety of ombitasvir/paritaprevir/ritonavir and ribavirin for chronic hepatitis patients infected with genotype 2a in JapanMasanori Atsukawa, Akihito Tsubota, Hidenori Toyoda, et al.British Journal of Cancer|March 30, 2016
Long-term impact of liver function on curative therapy for hepatocellular carcinoma: application of the ALBI gradeHidenori Toyoda, Paul B S Lai, James O'Beirne, et al.Hepatology Research : the Official Journal of the Japan Society of Hepatology|February 7, 2026
Prognostic Value of an Early Response to Tolvaptan and Its Clinical Implications in Patients With Cirrhosis and Hepatic Edema: A Nationwide Multicenter Cohort StudyKaori Koyano, Taeang Arai, Hidenori Toyoda, et al.Pageof 33